Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • November 2022
  • Case
  • HBS Case Collection

The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales

By: Regina E. Herzlinger and Tiffany Farrell
  • Format:Print
  • | Language:English
  • | Pages:31
ShareBar

Abstract

Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous technological innovation has developed a direct-to-consumer (DTC) channel that could upend the standard model of pharmaceutical insurance and pharmacy benefit manager channels that dominate the industry. But UpScript’s reliance on self-investment constrains it from access to the capital it now needs to grow and remain at the forefront of its ability to provide pharma with this sales channel. With whom should UpScript invest to maintain growth and market leadership? And as it grows, how will UpScript be challenged by the deeply entrenched pharmacy benefit managers that currently cover most American lives? And how does UpScript stay ahead of the other online pharmacies or telehealth businesses offering a DTC sales channel, mostly for lifestyle generic drugs?

This case is suitable both as a general business case for undergraduate and MBA students of any level, focused on strategy, entrepreneurship, DTC pharmaceutical strategies, the pharmaceutical sector, regulation of pharmaceutical marketing and advertising, pharmaceutical benefit managers, and the healthcare industry.

Keywords

DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Pharmaceutical Industry; Health Industry; Retail Industry

Citation

Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
  • Educators
  • Purchase

About The Author

Regina E. Herzlinger

General Management
→More Publications

More from the Authors

    • September 2023
    • Faculty Research

    Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment

    By: Regina E. Herzlinger
    • September 2023
    • Faculty Research

    Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment

    By: Regina E. Herzlinger
    • August 2023
    • Faculty Research

    Parexel (B): The Future of the CRO Industry

    By: Regina E. Herzlinger and Ben Creo
More from the Authors
  • Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment By: Regina E. Herzlinger
  • Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment By: Regina E. Herzlinger
  • Parexel (B): The Future of the CRO Industry By: Regina E. Herzlinger and Ben Creo
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College